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Aos que vêem o belo onde os outros apenas vêem a forma. 
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Abstract: 
 
Background: 
Beauty represents a proportional harmony in geometrical relations applied to all standards proposed to 
society. The Golden Number’s a proportion seen in this aesthetic harmony. Fibonacci Sequence’s a 
mathematical sequence where each number’s defined by the sum of the 2 preceding numbers. The ratio 
of this 2 successive numbers’ taken to its infinite term, called Phi, whose value’s 1,618.  
The Golden Ratio (GR) can be applied in almost every distribution of structures in nature and in human 
body. Human organs like heart or skull follow this rule. Until now this proportion wasn’t applied to the 
human brain. 
The aim of his study’s to determine if the normal human brain follows the GR, particularly if the 
cerebrum and corpus callosum anatomy respects the divine proportions, if the ratio of the measures is 
1,618. 
Method: 
We analyzed 100 normal brain MRI, measured the longitudinal and transversal proportions of the 
cerebrum and the corpus callosum and calculated the ratio between then.  
We calculated the mean and the standard ratio to both ratios, than we compared the actual mean to the 
hypothetical mean (1,618) and based on it we determine if the difference’s statistically significant (p 
value). We also calculated the upper limit (UL) and lower limit (LL)  (95% CI) and the maximum, 
minimum and median. 
Results:  
Cerebrum: Mean 1,621 (p-value=0,532), UL 1,632, LL 1,611. 
Corpus callosum: Mean 1,651 (p-value<0,0001), UL 1,663, LL 1,638. 
Conclusions: 
The normal cerebrum respects the GR. Alterations in these measures can lead to early diagnosis of 
different pathologies. 
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Introduction: 
  
 For those who contemplate beauty, feeling the stimulus that it causes in our senses is like to 
meet a world that confers real meaning on life. Artists, philosophers and scientists have tried in their 
works unravel the mystery and charm of beauty concepts. 
 Beauty represents a proportional harmony in numerical and geometrical relations applied to 
almost all standards proposed to society.  
 In the fifth century BC, the Greek sculptor Phidias repeatedly applied the Golden Ratio to 
his works and in his honor the Golden Number is represented by the Greek letter Φ (Phi). The Phi 
Number corresponds to 1,618. According to the Golden Proportion, the ideal ratio is 1 cm to 1,618 cm, 
which is the equilibrium between all things and the perfect symmetry. So the Phi number has been 
known as the Divine Proportion.  
 For many years people have been seeking the perfect beauty and the ideal proportion. The 
Greeks created the Golden Rectangle, a rectangle with defined ratios (the long side divided by the 
smaller side is always 1,618) and from that proportion everything was built. So, they built the 
Parthenon (starting by a proportion of the rectangle forming the central and lateral side); either, the 
depth divided by length or height follows the ideal ratio of 1,618. The Egyptians did the same with the 
pyramids - each stone was 1,618 times greater than the stone above.(1) 
 In 1200, Leonardo Fibonacci, a mathematician who studied the growth of rabbit 
populations, created what is probably the most famous mathematical sequence: the Fibonacci 
Sequence. From one pair of rabbits, Fibonacci observed that their number increased from breeding 
several generations and came to a sequence, where a number is the sum of the two preceding numbers: 
 
1 
1+1=2 
1+2=3 
2+3=5 
3+5=8 
5+8=13 
8+13=21 
13+21=34 
 
The average rate of the growth series is 1,618... 
 When we analyze the natural world, it becomes clear that the distribution of most structures 
follows the golden ratio. The distribution of tree branches, petals, flowers and so on, obeys the golden 
rule. The leaves along a branch are arranged by this proportionality and they never stand exactly one 
below the other. In fact, each leaf is positioned 1,618 below and beside the other and because of this 
rainwater and sunlight will reach all sequentially.  
 The Vitruvian Man by Leonardo Da Vinci is used as aesthetic reference to the basic 
symmetry and proportions of the human body applied to the design of human beauty and harmonious 
relations between the parts that make up our body. Da Vinci applied these ideas to the human anatomy 
in his depiction of the perfect man, and the Vitruvian Man dimensions obey the golden ratio, which 
represents the expression of a man with the ideal proportions. In the Vitruvian Man, the human body is 
shown at the same time, inside two figures (a circle and a square), and the navel is the gravitational 
center of the human figure, which coincides with the center of two geometric figures. The total area of 
the circle is identical to the total area of the square and this pattern can be considered a mathematical 
algorithm to calculate the value of the irrational number Phi.(1)  
 By looking into the human body, we can conclude that there are also "divine rules". For 
example, in the lungs, the blood vessels follow the same procedure that branches or tree roots, which 
are divided in numbers reflecting the Fibonacci series. 
At birth, the navel divides the body into equal parts, but after 13 years, the navel divides the body in 
the golden ratio: the bottom is 1,618 times higher.  
The ratio between arm length and the measured from the elbow to the fingers is 1,618. About the 
fingers, if we divide the measure of the entire finger by the length from the proximal phalanx to the tip 
of the finger; or if we divide the measure from the proximal phalanx to the end, by the distance 
between the distal phalanx to the end, the result will be 1,618. The whole leg divided by measurement 
from knee size to the ground is 1,618. (3) 
 The skull height divided by the length of the jaw to the tip of the head is 1,618. (4) In the 
healthy heart, the ratio between the vertical and transverse dimensions is 1,618. In the ventricles, the 
mitral ring respects the divine proportions. (2) 
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 The cerebrum and the corpus callosum are presented as having a spiraloid structure 
according to the mathematical standard of the Golden Ratio. However, if we approach the vertical and 
transverse measurements of the corpus callosum, we can infer if it will be or not be in the golden ratio.  
 Therefore, this study aims to determine whether the human brain - more specifically the 
anatomy of the cerebrum and corpus callosum - respects the divine proportions, that is, if the ratio of 
the measures of this structure gives the value Phi (1,618).  
 In view of the foregoing we infer about the understanding of and admiration for the order 
and beauty of the human body and the world we live. 
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Material and Methods: 
 
 We analyzed 100 normal brain MRI, 43 females and 57 males with ages between 18 and 80 
years old.  
 We excluded any MRI with the existence of mass effect or brain tumors, compression 
effect, demyelinating disease - multiple sclerosis, progressive multifocal leukoencephalopathy -, and 
anatomical genetic abnormality, corpus callosum dysgenesis, or anencephaly. 
 On these imaging we measured the corpus callosum along two perpendicular lines (line “a” 
and line “b”)– as we demonstrate in Figure 1. The first leaves the most anterior point of the knee of the 
corpus callosum to the most posterior point of the rostrum of the corpus callosum. Perpendicularly to 
this, we traced another line, tangent to the anterior commissure, which delimits the uppermost points 
and bottom of the corpus callosum.  
 We also measured the cerebrum – as shown in Figure 2 - through a longitudinal straight line 
from the most anterior point of the frontal lobe to the most posterior point of the occipital lobe (line 
“b”); and another transverse cross since the uppermost point of the frontal lobe to the lowest point in 
the brain, the temporal lobe (line “a”).  
 Finally we calculated the ratio between the highest and the lowest straight to both brain 
structures.  
 Statistical analysis was performed with SPSS 22.0 software package. 
 We calculated the mean, we compared it to the hypothetical mean (Phi) and calculated the 
difference between these two values. We also calculated the standard deviation and the upper and the 
lower limit to a 95% CI and we checked if the mean was contained in the range of those values. Finally 
we noted the maximum, the minimum and the median to the both ratios of cerebrum and corpus 
callosum. 
 To the analysis, the variables that showed significance at p<0,20 were included. A p-
value<0,05 was used as the criterion for a statistical significance. The results are expressed with a 95% 
confidence interval.  
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Results: 
 
 The results of measures and the quotient between the measures of the cerebrum and the corpus 
callosum are both provided in Table 1. The 95% confidence interval for the ratio of the cerebrum and 
the corpus callosum are presented in Table 2.  
Phi (Fibonacci Number), which is 1,618, is contained in the 95% confidence interval only for 
the quotient of the cerebrum proportions.  
The actual mean to cerebrum is 1,621 and the difference between that and the hypothetical 
mean (witch is Phi) is 0,003 and the two-tailed p-value equals 0,532 – as presented in Table 2. So by 
the criteria this difference is considered to be not statistically significant. 
 The minimum value to the ratio of cerebrum’s measures is 1,433 and the maximum is 1,790 – 
as we can observe in Table 3, where we present the median of the values too. 
 The statistic analysis to the corpus callosum is presented in Tables 2 and 3. The mean of ratio 
is 1,651 and the difference between that and the Golden Number is 0,033, so the two-tailed p-value is 
less than 0,0001. Because of that this difference is considered to be extremely statistically significant. 
To this aim we can conclude that the ratio of the corpus callosum measures did not contain 
Phi so this structure does not respect the Golden Ratio. 
The results of the quotient between the measures of the cerebrum are presented on Graphic 1, 
the ratio of the corpus callosum measures are provided on Graphic 2, and the parallel of both ratio is 
presented on Graphic 3. 
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Discussion:  
 
About the cerebrum and corpus callosum, despite having a spiraloid structure, nobody knows 
if it is a perfect spiral according to the Golden Ratio and the Fibonacci Sequence 
Leonardo Fibonacci described the most famous mathematical sequence - the Fibonacci 
Sequence - in the 13th century. Starting with one pair of rabbits, Fibonacci observed that their number 
increased from breeding several generations and came to a sequence.(1) In Fibonacci Sequence each 
number is defined by the sum of the 2 preceding numbers (0, 1, 0+1=1, 1+1=2, 1+2=3, 2+3=5, 3+5=8, 
5+8=13, 8+13=21, 13+21=34, 21+34=55, 34+55=89, and so forth).  
The Golden Rule can be applied to almost every distribution of structures in nature, such as 
the distribution of tree branches or the localization of the leaves along a branch; in the human body the 
Fibonacci sequence can be applied to the blood vessels in the lungs, to the phalanges of the fingers (3), 
to hearth dimensions(4), or to the aesthetic standards of the face.(2) 
The ratio of 2 successive numbers in Fibonacci’s Sequence is taken to its infinite term, called 
Phi whose value is 1,618.  
The Golden Square is a square where the ratio of longitudinal and transversal measures is 
1,618 (Phi).(1)  
In this study, it was verified that the ratio of the cerebrum longitudinal and transversal 
measures was approximated Phi, to a 95% Confidence Interval (p=0,05), with the lower limit 1,611 and 
the upper limit 1,632. The corpus callosum was equally measured and we concluded that the ratio 
wasn’t nearly Phi, because the lower limit is 1,638 - which is more than 1,618 -, and the upper limit is 
1,663. 
As we can conclude from Graphic 3, the values of the ratio of the corpus callosum and the 
cerebrum fluctuate the same way despite some points of divergence. 
However, in spite of the similar ratio variation, we note that the corpus callosum ratio values 
are slightly higher than those of the cerebrum in almost all of the measurements, which explains why, 
for the same confidence interval, the proportions of the cerebrum are in accordance with the Golden 
Ratio and corpus callosum proportions are not, although the difference of the quotients is in fact very 
small – the lower limit of corpus callosum ratio is only 1,68% bigger than the lower limit of the 
cerebrum ratio, and it is 1,2% bigger than Phi. 
Therefore, we conclude that the corpus callosum does not have the Divine Proportions but it 
has ratios close to this standard. 
Furthermore, we can conclude that the human cerebrum has the Golden Proportion, and about 
that we can establish a relation with the Golden Rectangle. 
The Golden Rectangle is a figure whose the quotient between the longitudinal and transversal 
proportions is 1,618. From a Golden Rectangle we can construct a perfect spiral by the Fibonacci 
Sequence – the Golden Spiral. 
If we divide a golden rectangle into a square and a rectangle, the new rectangle will also have the 
divine proportions. Repeating the process and dividing this new rectangle into a square and rectangle 
we will have a Golden Rectangle again. Now, if we do this procedure infinitely and unite the corners of 
the generated square, we get a Golden Spiral. (1) 
Therefore, if we apply the previous procedure to the Golden Rectangle formed by the human cerebrum 
proportions, we can also build a Divine Spiral associated to the Cerebrum, such as we can see on 
Figure 3. 
So, we can conclude that the human cerebrum is a Golden Spiral. 
On the other hand, the corpus callosum - the other structure we measured in this study – 
doesn’t have the divine proportions, and because of this, it is not possible to build, from the corpus 
callosum, a rectangle and consequently a spiral according to the values of the Fibonacci Sequence. 
 Thus, we conclude that the corpus callosum - despite this spiraloid structure - is not a 
perfect spiral by the Fibonacci Sequence. 
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Conclusion: 
 
 The normal cerebrum respects the Golden Ratio.  
 This study enables us to infer that brains whose cerebrum proportions are inconsistent with 
the Golden Rule can match unhealthy brains. 
 Thus, through the longitudinal and transverse measures and their ratio, it may be possible, 
in the future, to indicate early stages of different pathologies and this can lead to early diagnosis. 
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Attachments: 
Table 1 
    Corpus Callosum  Cerebrum 
 Age Genre  Length Height Ratio  Length Height Ratio 
1.  49 M  49,7 29,9 1,662  164,9 101,4 1,626 
2.  49 M  51,1 30,3 1,686  163,3 102,2 1,598 
3.  91 F  55,0 33,9 1,622  150,7 89,7 1,680 
4.  91 F  63,9 39,3 1,626  155,5 100,2 1,552 
5.  66 M  64,3 39,2 1,640  155,1 100,8 1,539 
6.  80 M  49,4 30,2 1,636  159,2 98,2 1,621 
7.  52 F  45,2 27,8 1,626  162,6 100,6 1,616 
8.  41 F  44,4 26,7 1,663  149,2 92,8 1,608 
9.  49 M  53,9 32,3 1,669  153,2 95,8 1,599 
10.  49 M  43,9 27,7 1,585  148,4 89,4 1,660 
11.  58 F  44,8 26,8 1,672  144,4 86,5 1,669 
12.  35 M  49,0 28,7 1,707  160,0 97,5 1,641 
13.  35 M  47,7 28,8 1,656  158,1 94,4 1,675 
14.  57 F  46,0 28,0 1,643  150,4 96,0 1,567 
15.  65 M  54,7 32,8 1,668  161,8 101,3 1,597 
16.  43 F  58,5 36,0 1,625  165,2 102,2 1,616 
17.  65 F  50,1 29,7 1,687  157,5 98,3 1,602 
18.  32 F  50,3 31,0 1,623  159,9 98,0 1,632 
19.  35 F  40,7 27,1 1,502  165,1 99,9 1,653 
20.  48 F  46,2 27,6 1,674  147,0 92,5 1,589 
21.  41 M  54,3 32,6 1,666  160,8 95,6 1,682 
22.  22 F  45,7 27,9 1,638  153,5 85,8 1,789 
23.  42 M  45,1 27,4 1,646  159,8 99,6 1,604 
24.  82 M  45,8 28,4 1,613  153,2 90,8 1,687 
25.  49 F  55,7 33,7 1,653  159,0 98,3 1,617 
26.  63 M  51,8 30,4 1,704  160,2 101,6 1,577 
27.  36 F  46,7 29,1 1,605  154,5 99,4 1,554 
28.  68 M  48,8 30,3 1,611  152,3 94,5 1,612 
29.  58 M  58,8 36,1 1,629  159,5 98,5 1,619 
30.  37 F  51,9 30,3 1,713  161,1 99,8 1,614 
31.  47 M  49,4 30,3 1,630  151,9 89,9 1,690 
32.  53 F  43,2 26,7 1,618  153,1 97,8 1,565 
33.  54 F  50,8 31,0 1,639  159,3 102,5 1,554 
34.  26 F  50,7 31,2 1,625  157,2 94,2 1,669 
35.  45 F  51,9 30,3 1,713  160,3 99,9 1,605 
36.  38 F  52,2 32,8 1,591  157,0 93,4 1,681 
37.  55 M  46,3 27,4 1,690  155,4 97,0 1,602 
38.  68 M  45,7 27,5 1,662  149,2 92,8 1,608 
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39.  53 M  58,8 36,1 1,629  150,7 89,7 1,680 
40.  35 F  47,9 29,8 1,607  160,0 97,9 1,634 
41.  68 M  51,9 30,3 1,713  155,5 100,2 1,552 
42.  47 F  51,7 30,8 1,679  159,5 99,0 1,611 
43.  68 F  50,4 30,5 1,652  152,7 95,4 1,601 
44.  66 F  55,8 31,9 1,749  151,9 90,1 1,686 
45.  64 M  43,2 26,7 1,618  155,1 100,8 1,539 
46.  40 M  51,7 30,9 1,673  170,0 103,2 1,647 
47.  57 F  55,2 34,1 1,619  157,8 98,1 1,609 
48.  58 M  48,8 30,3 1,611  163,3 102,2 1,598 
49.  63 F  50,6 29,8 1,698  153,9 91,7 1,678 
50.  70 F  53,4 31,8 1,679  168,0 103,9 1,617 
51.  61 F  55,2 33,9 1,628  159,3 99,1 1,607 
52.  54 F  49,2 30,2 1,629  158,0 102,4 1,543 
53.  50 F  45,6 28,1 1,623  152,1 94,1 1,616 
54.  54 M  55,7 33,7 1,653  160,0 100,4 1,594 
55.  64 M  45,8 28,4 1,613  152,5 96,3 1,584 
56.  52 F  50,4 30,6 1,647  154,7 95,5 1,620 
57.  48 F  50,5 32,0 1,578  164,4 101,9 1,613 
58.  51 M  53,4 31,8 1,679  168,1 104,0 1,616 
59.  41 F  47,8 29,5 1,620  158,9 97,6 1,628 
60.  67 M  54,8 32,7 1,676  152,9 94,2 1,623 
61.  56 F  47,2 28,0 1,686  148,2 89,0 1,665 
62.  77 M  54,2 32,2 1,683  157,0 100,9 1,556 
63.  59 F  55,9 32,1 1,741  156,1 91,0 1,715 
64.  32 F  39,1 24,7 1,583  156,6 93,6 1,673 
65.  43 F  49,9 29,8 1,674  147,0 91,1 1,614 
66.  45 F  50,0 29,4 1,701  157,6 98,5 1,600 
67.  41 M  50,5 26,3 1,920  162,4 102,5 1,584 
68.  52 F  46,5 28,3 1,643  153,8 95,9 1,604 
69.  25 F  47,6 28,9 1,647  153,7 92,9 1,654 
70.  80 M  60,1 35,9 1,674  161,1 94,8 1,699 
71.  29 F  52,1 30,7 1,697  166,0 98,9 1,678 
72.  54 F  48,5 30,1 1,611  145,6 94,4 1,542 
73.  28 M  56,1 34,8 1,612  170,0 103,1 1,649 
74.  27 M  46,6 27,5 1,695  154,8 95,6 1,619 
75.  55 F  60,5 38,6 1,567  155,0 96,5 1,606 
76.  26 M  40,8 28,6 1,427  153,4 99,2 1,546 
77.  80 F  83,6 50,8 1,646  181,8 107,5 1,691 
78.  49 F  62,2 34,6 1,798  154,5 107,8 1,433 
79.  40 M  49,7 32,1 1,548  169,8 108,4 1,566 
80.  45 F  46,1 27,5 1,676  147,0 82,1 1,790 
81.  72 F  50,4 30,3 1,663  153,2 90,2 1,698 
82.  75 F  56,2 32,0 1,756  159,2 101,2 1,573 
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83.  39 M  50,5 30,2 1,672  152,1 89,7 1,696 
84.  72 F  47,6 29,0 1,641  152,1 94,1 1,616 
85.  41 F  51,8 26,5 1,955  152,5 96,3 1,584 
86.  40 M  53,8 32,7 1,645  160,0 100,4 1,594 
87.  57 F  45,9 27,8 1,651  158,5 94,6 1,675 
88.  29 F  54,3 33,4 1,626  158,9 97,2 1,635 
89.  21 F  49,9 30,0 1,663  158,9 92,8 1,712 
90.  45 F  46,2 28,3 1,633  159,3 98,5 1,617 
91.  42 M  49,4 30,3 1,630  159,2 98,2 1,621 
92.  57 F  45,2 27,8 1,626  151,8 93,9 1,617 
93.  18 M  46,5 28,4 1,637  162,6 100,6 1,616 
94.  58 F  49,4 30,3 1,630  157,3 99,1 1,587 
95.  55 M  46,5 28,4 1,637  153,7 95,3 1,613 
96.  37 M  51,1 34,5 1,481  162,9 106,2 1,534 
97.  64 M  45,7 27,5 1,662  151,9 89,9 1,690 
98.  30 M  45,6 28,1 1,623  162,2 101,3 1,601 
99.  43 F  57,7 36,0 1,603  161,3 99,8 1,616 
100.  63 M  57,5 35,9 1,602  159,4 100,2 1,591 
Table 2 
 Mean p-value Standard 
Ratio 
Confidence 
Interval 95% 
Upper Limit Lower 
Limit 
Corpus 
Callosum 
1,651 < 0,0001 0,066 0,013 1,663 1,638 
Cerebrum 1,621 0,532 0,053 0,010 1,632 1,611 
Table 3 
 Median Maximum Minimum 
Corpus 
Callosum 
1,644 1,955 1,427 
Cerebrum 1,616 1,790 1,433 
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Please state clearly the format of your paper, i.e. Clinical Investigation, Case Report, Experimental 
Research, Letter to the Editor, Review Article, Technical Note.  
Reports of Clinical, Experimental Research, Review Articles or Technical Notes.  
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materials, results, discussion, references.  
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words). Four to six keywords should be provided.  
• The introduction should summarise the underlying purpose of the paper.  
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experiments and how they were done, the characteristics of patients or other humans participating as 
subjects, the nature of observations made and the specific approach to statistical considerations. This 
section should enable the reader to analyse, to repeat or to continue the work presented.  
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and analysed concisely. Finally, the implications of the findings of the study for advancing knowledge 
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Case reports.  
Case reports should be limited to 6 pages of typescript (1500 words), including tables and illustrations. 
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deductions can be drawn.  
Letters to the Editor should be a maximum of 750 words and may include a table or figure and 
references. The format for submissions of editorials, reviews, personal communications, concept 
articles, biographies and historical articles can be varied as appropriate to the topic, consistent with 
clarity and brevity.  
How I do It  
This new section in the journal is for showing how surgical procedures are carried out.  
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Manuscript Submission  
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not under consideration for publication anywhere else; that its publication has been approved by all 
co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where 
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claims for compensation.  
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received without such evidence will be assumed to originate from the authors.  
Online Submission  
Please follow the hyperlink “Submit online” on the right and upload all of your manuscript files 
following the instructions given on the screen.  
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Ethical standards  
Manuscripts submitted for publication must contain a statement to the effect that all human and animal 
studies have been approved by the appropriate ethics committee and have therefore been performed in 
accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later 
amendments.  
It should also be stated clearly in the text that all persons gave their informed consent prior to their 
inclusion in the study. Details that might disclose the identity of the subjects under study should be 
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If no conflict exists, authors should state: The authors declare that they have no conflict of interest.  
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decision on accepting the change rests with the Editor- in-Chief of the journal and may be turned down. 
Therefore authors are strongly advised to ensure the correct author group, corresponding author, and 
order of authors at submission.  
Upon request authors should be prepared to send relevant documentation or data in order to verify the 
validity of the results. This could be in the form of raw data, samples, records, etc.  
If there is a suspicion of misconduct, the journal will carry out an investigation following the COPE 
guidelines. If, after investigation, the allegation seems to raise valid concerns, the accused author will 
be contacted and given an opportunity to address the issue. If misconduct has been established beyond 
reasonable doubt, this may result in the Editor-in-Chief’s implementation of the following measures, 
including, but not limited to:  
If the article is still under consideration, it may be rejected and returned to the author. If the article has 
already been published online, depending on the nature and severity of the infraction, either an erratum 
will be placed with the article or in severe cases complete retraction of the article will occur. The 
reason must be given in the published erratum or retraction note.  
The author’s institution may be informed.  
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To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and 
professional conduct have been followed, authors should include information regarding sources of 
funding, potential conflicts of interest (financial or non-financial), informed consent if the research 
involved human participants, and a statement on welfare of animals if the research involved animals.  
Authors should include the following statements (if applicable) in a separate section entitled 
“Compliance with Ethical Standards” when submitting a paper:  
Disclosure of potential conflicts of interest Research involving Human Participants and/or Animals 
Informed consent  
Please note that standards could vary slightly per journal dependent on their peer review policies (i.e. 
single or double blind peer review) as well as per journal subject discipline. Before submitting your 
article check the instructions following this section carefully.  
The corresponding author should be prepared to collect documentation of compliance with ethical 
standards and send if requested during peer review or after publication.  
The Editors reserve the right to reject manuscripts that do not comply with the above-mentioned 
guidelines. The author will be held responsible for false statements or failure to fulfill the above- 
mentioned guidelines.  
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and objective assessment of the work. Awareness of a real or perceived conflicts of interest is a 
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inappropriate. Examples of potential conflicts of interests that are directly or indirectly related to 
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In addition, interests that go beyond financial interests and compensation (non-financial interests) that 
may be important to readers should be disclosed. These may include but are not limited to personal 
relationships or competing interests directly or indirectly tied to this research, or professional interests 
or personal beliefs that may influence your research.  
The corresponding author collects the conflict of interest disclosure forms from all authors. In author 
collaborations where formal agreements for representation allow it, it is sufficient for the 
corresponding author to sign the disclosure form on behalf of all authors. Examples of forms can be 
found here:  
The corresponding author will include a summary statement in the text of the manuscript in a separate 
section before the reference list, that reflects what is recorded in the potential conflict of interest 
disclosure form(s).  
Please make sure to submit all Conflict of Interest disclosure forms together with the manuscript.  
See below examples of disclosures: Funding: This study was funded by X (grant number X).  
Conflict of Interest: Author A has received research grants from Company A. Author B has received a 
speaker honorarium from Company X and owns stock in Company Y. Author C is a member of 
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 RESEARCH INVOLVING HUMAN PARTICIPANTS AND/OR ANIMALS  
1) Statement of human rights  
When reporting studies that involve human participants, authors should include a statement that the 
studies have been approved by the appropriate institutional and/or national research ethics committee 
and have been performed in accordance with the ethical standards as laid down in the 1964 Declaration 
of Helsinki and its later amendments or comparable ethical standards.  
If doubt exists whether the research was conducted in accordance with the 1964 Helsinki Declaration 
or comparable standards, the authors must explain the reasons for their approach, and demonstrate that 
the independent ethics committee or institutional review board explicitly approved the doubtful aspects 
of the study.  
The following statements should be included in the text before the References section:  
Ethical approval: “All procedures performed in studies involving human participants were in 
accordance with the ethical standards of the institutional and/or national research committee and with 
the 1964 Helsinki declaration and its later amendments or comparable ethical standards.”  
For retrospective studies, please add the following sentence: “For this type of study formal consent is 
not required.”  
2) Statement on the welfare of animals  
The welfare of animals used for research must be respected. When reporting experiments on animals, 
authors should indicate whether the international, national, and/or institutional guidelines for the care 
and use of animals have been followed, and that the studies have been approved by a research ethics 
committee at the institution or practice at which the studies were conducted (where such a committee 
exists).  
For studies with animals, the following statement should be included in the text before the References 
section:  
Ethical approval: “All applicable international, national, and/or institutional guidelines for the care 
and use of animals were followed.”  
If applicable (where such a committee exists): “All procedures performed in studies involving animals 
were in accordance with the ethical standards of the institution or practice at which the studies were 
conducted.”  
If articles do not contain studies with human participants or animals by any of the authors, please select 
one of the following statements:  
“This article does not contain any studies with human participants performed by any of the authors.”  
“This article does not contain any studies with animals performed by any of the authors.”  
“This article does not contain any studies with human participants or animals performed by any of the 
authors.”  
INFORMED CONSENT  
All individuals have individual rights that are not to be infringed. Individual participants in studies 
have, for example, the right to decide what happens to the (identifiable) personal data gathered, to what 
they have said during a study or an interview, as well as to any photograph that was taken. Hence it is 
important that all participants gave their informed consent in writing prior to inclusion in the study. 
Identifying details (names, dates of birth, identity numbers and other information) of the participants 
that were studied should not be published in written descriptions, photographs, and genetic profiles 
unless the information is essential for scientific purposes and the participant (or parent or guardian if 
the participant is incapable) gave written informed consent for publication. Complete anonymity is 
difficult to achieve in some cases, and informed consent should be obtained if there is any doubt. For 
example, masking the eye region in photographs of participants is inadequate protection of anonymity. 
If identifying characteristics are altered to protect anonymity, such as in genetic profiles, authors 
should provide assurance that alterations do not distort scientific meaning.  
The following statement should be included:  
Informed consent: “Informed consent was obtained from all individual participants included in the 
study.”  
If identifying information about participants is available in the article, the following statement should 
be included:  
“Additional informed consent was obtained from all individual participants for whom identifying 
information is included in this article.”  
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